APA (7th ed.) Citation

Drevin, G., Briet, M., Bazzoli, C., Gyan, E., Schmidt, A., Dombret, H., . . . Abbara, C. (2022). Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial. Pharmaceutics, 14(4), N.PAG. https://doi.org/10.3390/pharmaceutics14040792

Chicago Style (17th ed.) Citation

Drevin, Guillaume, et al. "Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial." Pharmaceutics 14, no. 4 (2022): N.PAG. https://doi.org/10.3390/pharmaceutics14040792.

MLA (9th ed.) Citation

Drevin, Guillaume, et al. "Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial." Pharmaceutics, vol. 14, no. 4, 2022, p. N.PAG, https://doi.org/10.3390/pharmaceutics14040792.